C. Ezzili

发表

Fatty acid amide signaling molecules.

Dale L Boger, D. Boger, C. Ezzili, 2010, Bioorganic & medicinal chemistry letters.

The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

D. Boger, C. Ezzili, K. Otrubova, 2011, Bioorganic & medicinal chemistry letters.

Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

D. Boger, R. Stevens, J. Long, 2011, Journal of medicinal chemistry.

X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Raymond C Stevens, Dale L Boger, D. Boger, 2010, Journal of medicinal chemistry.

Combination of Olaparib and radiotherapy for triple negative breast cancer: preliminary results of the RADIOPARP phase I trial.

A. Vincent-Salomon, C. Ezzili, A. Fourquet, 2020, International journal of radiation oncology, biology, physics.

The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice

D. Boger, J. Long, B. Cravatt, 2012, British journal of pharmacology.

Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.

D. Boger, R. Stevens, B. Cravatt, 2011, Journal of the American Chemical Society.

Optimization of α -Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase

D. Boger, F. A. Romero, C. Ezzili, 2009 .

Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients

M. Gobbi, M. Sablin, C. Ezzili, 2014, Cancer Chemotherapy and Pharmacology.

Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

D. Boger, C. Ezzili, Dustin G Hochstatter, 2008, Journal of medicinal chemistry.

Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Dale L Boger, D. Boger, F. A. Romero, 2008, Journal of medicinal chemistry.

Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

D. Boger, C. Ezzili, T. Rayl, 2008, Journal of medicinal chemistry.

Radioparp: A phase I of olaparib with radiation therapy (RT) in patients with inflammatory, locoregionally advanced or metastatic triple-negative breast cancer (TNBC) or patient with operated TNBC with residual disease—Preliminary results.

A. Salomon, J. Pierga, C. Ezzili, 2020 .